{"count":8,"index":{"built_at":"2026-07-27T13:19:15.919330+00:00","public_records":55311,"revision":"fa7509379c5f20c81fe599c0"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of menopause"},"results":[{"answer":"The 'Cardio Risk Check' in the context of menopause is a topic with mixed evidence. Menopause increases cardiovascular risk due to estrogen decline, affecting lipids, blood pressure, and vascular function. However, the predictive power of individual genetic tests (e.g., on TRH variants) for personal risk is low. The provided knowledge sources contain no specific study or guideline validating this test. Many commercial tests combine genetic markers with lifestyle factors, but effect sizes are small. Menopause itself is a stronger risk factor than most single nucleotide polymorphisms. Comprehensive cardiovascular screening (blood pressure, lipids, glucose) and lifestyle optimization are more evidence-based than isolated DNA testing. Evidence rating: mixed – mechanistic links exist, but clinical validity for consumer tests is often insufficient. No invented sources; statements are based on general physiological knowledge.","area":"gesundheit","canonical_id":"gesundheit:canonical-7eeef8c134b255e5c9c6c45e","id":"public-980fdc8947f9f2381d9beb5e","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of menopause","score":41.91781618,"snippet":"The 'Cardio Risk Check' in the context of menopause is a topic with mixed evidence. Menopause increases cardiovascular risk due to estrogen decline, affecting lipids, blood pressure, and vascular function. However, the predictive power of individual genetic tests (e.g., on TRH variants) for personal risk is low. The provided knowledge sources contain no specific study or guideline validating this test. Many commercial tests combine genetic markers with lifestyle factors, but effect sizes are small. Menopause itself is a stronger risk factor than most single nucleotide polymorphisms. Comprehensive cardiovascular screening (blood pressure, lipids, glucose) and lifestyle optimization are more e","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-980fdc8947f9f2381d9beb5e/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The usefulness of a Cardio Risk Check (cardiovascular risk test) during menopause cannot be fully assessed from the provided context. The context mentions general cardiovascular biomarkers such as LDL, ApoB, Lp(a), CRP, and homocysteine, which are supported by a systematic review for reflecting cardiovascular risk. Menopause increases cardiovascular risk due to hormonal changes (declining estrogen), so such a test could theoretically be beneficial. However, the context emphasizes that single biomarkers are insufficient and results must be interpreted by a doctor. No specific studies on menopause are cited. The test is a consumer product; marketing claims should be separated from evidence. Without direct data on menopause, the utility remains uncertain. Recommendation: consult a physician who can consider individual risk factors.","area":"gesundheit","canonical_id":"gesundheit:canonical-f2be0b6e206cc9cd0f25dd99","id":"public-c1fa0046b64a2363d24925b1","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for menopause?","score":41.6059094,"snippet":"The usefulness of a Cardio Risk Check (cardiovascular risk test) during menopause cannot be fully assessed from the provided context. The context mentions general cardiovascular biomarkers such as LDL, ApoB, Lp(a), CRP, and homocysteine, which are supported by a systematic review for reflecting cardiovascular risk. Menopause increases cardiovascular risk due to hormonal changes (declining estrogen), so such a test could theoretically be beneficial. However, the context emphasizes that single biomarkers are insufficient and results must be interpreted by a doctor. No specific studies on menopause are cited. The test is a consumer product; marketing claims should be separated from evidence. Wi","sources":[],"title":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for menopause?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c1fa0046b64a2363d24925b1/is-cardio-risk-check-herz-kreislauf-risiko-test-useful-for-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Whether the MyBody-X Cardio Risk Check | Herz-Kreislauf Risiko-Test can help with menopause cannot be determined from the provided knowledge context. Menopause increases cardiovascular risk due to declining estrogen, which can raise blood pressure, worsen lipid profiles, and promote insulin resistance. A cardiovascular risk test could theoretically assess relevant markers, but the context lacks any details about the test's design, whether it measures blood biomarkers or genetic variants, or if it is validated for perimenopausal women. Without this information, the evidence is unclear. Direct-to-consumer (DTC) tests often overstate the predictive power of individual markers. For menopausal women, established clinical assessments—such as blood pressure, lipid panels, fasting glucose, and a physician-calculated risk score—are far more reliable. The Cardio Risk Check might provide supplementary insight, but it should not replace standard medical evaluation. Safety note: Do not alter medications or lifestyle based solely on a DTC test without consulting a healthcare provider.","area":"gesundheit","canonical_id":"gesundheit:canonical-a158b70663b11d43d7710869","id":"public-eff5c0f8eb5c038c34b38b2d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Can Cardio Risk Check | Herz-Kreislauf Risiko-Test help with menopause?","score":41.32513712,"snippet":"Whether the MyBody-X Cardio Risk Check | Herz-Kreislauf Risiko-Test can help with menopause cannot be determined from the provided knowledge context. Menopause increases cardiovascular risk due to declining estrogen, which can raise blood pressure, worsen lipid profiles, and promote insulin resistance. A cardiovascular risk test could theoretically assess relevant markers, but the context lacks any details about the test's design, whether it measures blood biomarkers or genetic variants, or if it is validated for perimenopausal women. Without this information, the evidence is unclear. Direct-to-consumer (DTC) tests often overstate the predictive power of individual markers. For menopausal wo","sources":[],"title":"Can Cardio Risk Check | Herz-Kreislauf Risiko-Test help with menopause?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-eff5c0f8eb5c038c34b38b2d/can-cardio-risk-check-herz-kreislauf-risiko-test-help-with-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context documents contain no specific information linking the Cardio Risk Check (Herz-Kreislauf Risiko-Test) to menopause. It is well established that cardiovascular risk increases after menopause due to declining estrogen levels, affecting blood pressure, lipid profiles, and vascular function. A Cardio Risk Check, which typically includes biomarkers such as LDL, HDL, triglycerides, hsCRP, and possibly genetic risk variants (e.g., 9p21 locus), could therefore be particularly relevant for postmenopausal women. However, the available sources lack direct study data or product details to substantiate this connection. The evidence level is therefore classified as unclear. Consumers should be aware that such home tests are complementary, not a substitute, for medical screening. A physician consultation for risk stratification remains essential.","area":"gesundheit","canonical_id":"gesundheit:canonical-2fc426f52b8694ebd81f1ce1","id":"public-ad2118f692dfc9b3d17007e9","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and menopause related?","score":41.23342086,"snippet":"The provided context documents contain no specific information linking the Cardio Risk Check (Herz-Kreislauf Risiko-Test) to menopause. It is well established that cardiovascular risk increases after menopause due to declining estrogen levels, affecting blood pressure, lipid profiles, and vascular function. A Cardio Risk Check, which typically includes biomarkers such as LDL, HDL, triglycerides, hsCRP, and possibly genetic risk variants (e.g., 9p21 locus), could therefore be particularly relevant for postmenopausal women. However, the available sources lack direct study data or product details to substantiate this connection. The evidence level is therefore classified as unclear. Consumers s","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and menopause related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ad2118f692dfc9b3d17007e9/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-menopause-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of the Cardio Risk Check | Herz-Kreislauf Risiko-Test in menopause cannot be directly determined from the provided context, as neither the test nor menopause is mentioned in the given sources. Generally, cardiovascular risk increases after menopause due to declining estrogen levels. Such a test might theoretically help monitor risk factors like lipids or inflammatory markers. However, this appears to be a commercial test, and its clinical utility in menopause is not supported by strong evidence. Without specific studies or guidelines, its value remains unclear. Women in menopause should not rely solely on such tests but should seek medical advice for comprehensive risk assessment. The evidence grade is 'unclear' or 'marketing' due to lack of valid sources.","area":"gesundheit","canonical_id":"gesundheit:canonical-eca159e96dde8dc626ae916d","id":"public-4fa927815a0c2d3bdf0b09f0","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in Wechseljahre?","score":41.09832881,"snippet":"The role of the Cardio Risk Check | Herz-Kreislauf Risiko-Test in menopause cannot be directly determined from the provided context, as neither the test nor menopause is mentioned in the given sources. Generally, cardiovascular risk increases after menopause due to declining estrogen levels. Such a test might theoretically help monitor risk factors like lipids or inflammatory markers. However, this appears to be a commercial test, and its clinical utility in menopause is not supported by strong evidence. Without specific studies or guidelines, its value remains unclear. Women in menopause should not rely solely on such tests but should seek medical advice for comprehensive risk assessment. T","sources":[],"title":"What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-4fa927815a0c2d3bdf0b09f0/what-role-does-cardio-risk-check-herz-kreislauf-risiko-test-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specific risk markers. Therefore, the evidence for a direct connection between these particular DNA tests and menopause is unclear. A comprehensive risk assessment should include clinical parameters (blood pressure, lipids, fasting glucose) and lifestyle factors alongside genetic data. Interpretation requires medical guidance, especially during perimenopause.","area":"gesundheit","canonical_id":"gesundheit:canonical-dba57ce588eaf0504e5daffc","id":"public-1cba76d2e734dc592063d703","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","score":41.06920544,"snippet":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specif","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1cba76d2e734dc592063d703/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-wechseljahre-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Based on the provided context, there is no direct information about a 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' specifically for menopause. Generally, cardiovascular risk increases after menopause due to declining estrogen. Established clinical risk scores (e.g., SCORE2, Framingham) are validated for this period and recommended by guidelines. A consumer test that includes genetic markers (like MTHFR, ALDH2, FTO) or microbiome analysis may offer additional insights, but the evidence for its added value in menopause is limited. Many genetic associations come from GWAS and lack clinical actionability. Polygenic risk scores are less reliable for non-European populations. Therefore, such a test might be used as a supplementary tool, but it should not replace standard medical risk assessment. Caveat: Do not make health decisions based solely on a consumer test; consult a physician for interpretation and follow-up.","area":"gesundheit","canonical_id":"gesundheit:canonical-45110f7524e07c3fb34a7c83","id":"public-e8826844de6a23448ca20ca4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for Wechseljahre?","score":40.70870931,"snippet":"Based on the provided context, there is no direct information about a 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' specifically for menopause. Generally, cardiovascular risk increases after menopause due to declining estrogen. Established clinical risk scores (e.g., SCORE2, Framingham) are validated for this period and recommended by guidelines. A consumer test that includes genetic markers (like MTHFR, ALDH2, FTO) or microbiome analysis may offer additional insights, but the evidence for its added value in menopause is limited. Many genetic associations come from GWAS and lack clinical actionability. Polygenic risk scores are less reliable for non-European populations. Therefore, suc","sources":[],"title":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e8826844de6a23448ca20ca4/is-cardio-risk-check-herz-kreislauf-risiko-test-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":40.56163167,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}